{"nct_id":"NCT03768960","title":"A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2019-06-10","start_date_type":"ACTUAL","primary_completion_date":"2022-07-16","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-16","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["JNJ"]}